Project Scope

To understand and define the named patient program by conducting primary and secondary research to understand the approval process, funding, pricing, ordering process and product importation and distribution in each region

Challenge

Our client had a focus on Alzheimer’s disease research and treatment and wanted to understand the the process of establishing a Named Patient Program to allow unlicensed medicines to be made available for patients with Alzheimer’s Disease

Solution

Defined the Named Patient Program Pathway and Quantified Opportunity

• Conducted secondary research to understand the pre-approval approaches to patient access
• Conducted discussions with relevant stakeholders to understand the the criteria needed to establish a Named Patient Program, the approval process, funding and pricing of such medicines, the ordering process, as well as the product importation and distribution

Results

• Understood the key criteria and requirements from a disease and the unmet need perspective to establish a Named Patient Program
• Enabled our client to understand how to successfully implement a Named Patient Programme and set up a profitable opportunity in the post-approval setting